Log In
Print
BCIQ
Print
Print this Print this
 

rAAV2/2_ND4 (GS010)

  Manage Alerts
Collapse Summary General Information
Company GenSight Biologics S.A.
DescriptionGene therapy product containing the human ND4 gene
Molecular Target NADH dehydrogenase subunit 4 (ND4)
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Viral vector: Adeno-associated virus (AAV)
Latest Stage of DevelopmentPhase I/II
Standard IndicationOptic neuropathy
Indication DetailsTreat Leber's hereditary optic neuropathy (LHON)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today